HK Stock MarketDetailed Quotes

TSINGTAO BREW (00168)

Watchlist
  • 52.800
  • -1.100-2.04%
Market Closed May 6 16:07 CST
72.03BMarket Cap13.60P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TSINGTAO BREW (00168) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
-1.54%10.29B
1.04%32.47B
1.41%29.37B
2.11%20.49B
2.91%10.45B
-5.30%32.14B
-6.52%28.96B
-7.06%20.07B
-5.19%10.15B
5.49%33.94B
Operating income
-1.54%10.29B
1.04%32.47B
1.41%29.37B
2.11%20.49B
2.91%10.45B
-5.30%32.14B
-6.52%28.96B
-7.06%20.07B
-5.19%10.15B
5.49%33.94B
Operating expenses
3.40%-5.89B
1.69%-18.89B
1.89%-16.55B
1.55%-11.54B
-0.84%-6.1B
7.72%-19.21B
9.67%-16.87B
10.72%-11.72B
8.46%-6.05B
-2.46%-20.82B
Gross profit
1.08%4.4B
5.11%13.59B
6.01%12.82B
7.25%8.95B
5.96%4.35B
-1.46%12.93B
-1.73%12.09B
-1.37%8.35B
0.06%4.1B
10.68%13.12B
Selling expenses
9.61%-1.18B
2.58%-4.48B
0.62%-3.4B
-0.83%-2.19B
-0.55%-1.31B
2.25%-4.6B
1.79%-3.42B
9.16%-2.17B
12.16%-1.3B
-12.12%-4.71B
Administrative expenses
-7.59%-359.21M
-4.06%-1.46B
-2.39%-961.35M
-2.47%-682.99M
3.18%-333.87M
7.40%-1.41B
8.31%-938.92M
-1.76%-666.5M
-7.89%-344.83M
-3.10%-1.52B
Research and development expenses
-12.40%-20.18M
-18.57%-121.85M
-38.10%-78.36M
-48.65%-43.71M
-0.65%-17.95M
-2.12%-102.77M
-60.64%-56.74M
-32.70%-29.41M
-66.70%-17.83M
-59.86%-100.64M
Profit from asset sales
-95.25%1.52M
2,492.52%110.63M
872.08%109.46M
59,256.43%112.11M
99,750.89%31.97M
-97.61%4.27M
-44.47%11.26M
-101.71%-189.51K
-100.32%-32.08K
1,976.25%178.58M
Revaluation surplus
1,758.32%81.65M
-46.65%106.45M
-63.19%54.64M
-61.01%53.5M
-91.99%4.39M
-13.35%199.52M
-9.89%148.44M
7.64%137.22M
-12.01%54.87M
40.10%230.26M
-Changes in the fair value of other assets
1,758.32%81.65M
-46.65%106.45M
-63.19%54.64M
-61.01%53.5M
-91.99%4.39M
-13.35%199.52M
-9.89%148.44M
7.64%137.22M
-12.01%54.87M
40.10%230.26M
Impairment and provision
-5,222.76%-7.83M
49.86%-17.77M
76.12%-657.95K
82.14%-505.69K
76.57%-147.16K
63.53%-35.44M
-186.82%-2.75M
-492.54%-2.83M
-984.70%-628K
-548.63%-97.16M
-Other impairment is provision
-5,222.76%-7.83M
49.86%-17.77M
76.12%-657.95K
82.14%-505.69K
76.57%-147.16K
63.53%-35.44M
-186.82%-2.75M
-492.54%-2.83M
-984.70%-628K
-548.63%-97.16M
Special items of operating profit
-2.85%99.25M
-26.37%455.94M
-26.81%337.79M
-32.02%236.19M
-21.27%102.16M
9.95%619.2M
13.75%461.54M
32.24%347.44M
5.05%129.76M
-21.04%563.16M
Operating profit
8.28%2.38B
10.26%5.82B
8.45%6.83B
9.12%5.04B
8.97%2.2B
-0.08%5.28B
0.65%6.29B
5.52%4.62B
8.41%2.02B
15.27%5.28B
Financing income
-26.58%82.61M
-31.33%423.52M
-30.63%328.53M
-29.60%222.32M
-27.27%112.52M
21.80%616.77M
26.29%473.59M
33.41%315.78M
34.24%154.7M
210.16%506.38M
Financing cost
-68.86%-3.76M
46.67%-11.65M
51.68%-7.77M
56.63%-4.85M
62.49%-2.23M
-32.90%-21.84M
-140.29%-16.07M
-162.33%-11.17M
-108.62%-5.94M
-77.86%-16.43M
Special items of earning before tax
-77.78%1.09M
90.11%72.95M
937.63%33.98M
631.81%12.81M
361.59%4.93M
300.51%38.37M
-42.22%3.28M
-230.72%-2.41M
-62.50%1.07M
83.69%9.58M
Earning before tax
6.19%2.45B
6.96%6.29B
6.58%7.17B
7.20%5.26B
6.96%2.31B
2.35%5.88B
2.06%6.73B
6.64%4.91B
9.86%2.16B
14.79%5.75B
After-tax profit from continuing operations
5.43%1.83B
5.02%4.72B
5.30%5.4B
6.79%3.97B
7.07%1.74B
3.30%4.49B
2.63%5.13B
6.89%3.72B
10.19%1.62B
14.28%4.35B
Earning after tax
5.43%1.83B
5.02%4.72B
5.30%5.4B
6.79%3.97B
7.07%1.74B
3.30%4.49B
2.63%5.13B
6.89%3.72B
10.19%1.62B
14.28%4.35B
Minority profit
17.98%32.86M
-11.91%129.32M
-8.85%127.88M
-12.37%69.64M
6.16%27.85M
82.70%146.79M
53.83%140.3M
42.87%79.48M
18.82%26.24M
-14.61%80.35M
Profit attributable to shareholders
5.23%1.8B
5.60%4.59B
5.70%5.27B
7.21%3.9B
7.08%1.71B
1.81%4.34B
1.67%4.99B
6.31%3.64B
10.06%1.6B
15.02%4.27B
Basic earnings per share
5.18%1.319
5.39%3.363
5.45%3.867
7.11%2.862
6.72%1.254
1.66%3.191
1.52%3.667
6.20%2.672
9.71%1.175
14.73%3.139
Diluted earnings per share
5.18%1.319
5.52%3.363
5.63%3.866
7.11%2.862
7.00%1.254
1.76%3.187
1.58%3.66
6.24%2.672
9.94%1.172
14.81%3.132
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
PwC Zhongtian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover -1.54%10.29B1.04%32.47B1.41%29.37B2.11%20.49B2.91%10.45B-5.30%32.14B-6.52%28.96B-7.06%20.07B-5.19%10.15B5.49%33.94B
Operating income -1.54%10.29B1.04%32.47B1.41%29.37B2.11%20.49B2.91%10.45B-5.30%32.14B-6.52%28.96B-7.06%20.07B-5.19%10.15B5.49%33.94B
Operating expenses 3.40%-5.89B1.69%-18.89B1.89%-16.55B1.55%-11.54B-0.84%-6.1B7.72%-19.21B9.67%-16.87B10.72%-11.72B8.46%-6.05B-2.46%-20.82B
Gross profit 1.08%4.4B5.11%13.59B6.01%12.82B7.25%8.95B5.96%4.35B-1.46%12.93B-1.73%12.09B-1.37%8.35B0.06%4.1B10.68%13.12B
Selling expenses 9.61%-1.18B2.58%-4.48B0.62%-3.4B-0.83%-2.19B-0.55%-1.31B2.25%-4.6B1.79%-3.42B9.16%-2.17B12.16%-1.3B-12.12%-4.71B
Administrative expenses -7.59%-359.21M-4.06%-1.46B-2.39%-961.35M-2.47%-682.99M3.18%-333.87M7.40%-1.41B8.31%-938.92M-1.76%-666.5M-7.89%-344.83M-3.10%-1.52B
Research and development expenses -12.40%-20.18M-18.57%-121.85M-38.10%-78.36M-48.65%-43.71M-0.65%-17.95M-2.12%-102.77M-60.64%-56.74M-32.70%-29.41M-66.70%-17.83M-59.86%-100.64M
Profit from asset sales -95.25%1.52M2,492.52%110.63M872.08%109.46M59,256.43%112.11M99,750.89%31.97M-97.61%4.27M-44.47%11.26M-101.71%-189.51K-100.32%-32.08K1,976.25%178.58M
Revaluation surplus 1,758.32%81.65M-46.65%106.45M-63.19%54.64M-61.01%53.5M-91.99%4.39M-13.35%199.52M-9.89%148.44M7.64%137.22M-12.01%54.87M40.10%230.26M
-Changes in the fair value of other assets 1,758.32%81.65M-46.65%106.45M-63.19%54.64M-61.01%53.5M-91.99%4.39M-13.35%199.52M-9.89%148.44M7.64%137.22M-12.01%54.87M40.10%230.26M
Impairment and provision -5,222.76%-7.83M49.86%-17.77M76.12%-657.95K82.14%-505.69K76.57%-147.16K63.53%-35.44M-186.82%-2.75M-492.54%-2.83M-984.70%-628K-548.63%-97.16M
-Other impairment is provision -5,222.76%-7.83M49.86%-17.77M76.12%-657.95K82.14%-505.69K76.57%-147.16K63.53%-35.44M-186.82%-2.75M-492.54%-2.83M-984.70%-628K-548.63%-97.16M
Special items of operating profit -2.85%99.25M-26.37%455.94M-26.81%337.79M-32.02%236.19M-21.27%102.16M9.95%619.2M13.75%461.54M32.24%347.44M5.05%129.76M-21.04%563.16M
Operating profit 8.28%2.38B10.26%5.82B8.45%6.83B9.12%5.04B8.97%2.2B-0.08%5.28B0.65%6.29B5.52%4.62B8.41%2.02B15.27%5.28B
Financing income -26.58%82.61M-31.33%423.52M-30.63%328.53M-29.60%222.32M-27.27%112.52M21.80%616.77M26.29%473.59M33.41%315.78M34.24%154.7M210.16%506.38M
Financing cost -68.86%-3.76M46.67%-11.65M51.68%-7.77M56.63%-4.85M62.49%-2.23M-32.90%-21.84M-140.29%-16.07M-162.33%-11.17M-108.62%-5.94M-77.86%-16.43M
Special items of earning before tax -77.78%1.09M90.11%72.95M937.63%33.98M631.81%12.81M361.59%4.93M300.51%38.37M-42.22%3.28M-230.72%-2.41M-62.50%1.07M83.69%9.58M
Earning before tax 6.19%2.45B6.96%6.29B6.58%7.17B7.20%5.26B6.96%2.31B2.35%5.88B2.06%6.73B6.64%4.91B9.86%2.16B14.79%5.75B
After-tax profit from continuing operations 5.43%1.83B5.02%4.72B5.30%5.4B6.79%3.97B7.07%1.74B3.30%4.49B2.63%5.13B6.89%3.72B10.19%1.62B14.28%4.35B
Earning after tax 5.43%1.83B5.02%4.72B5.30%5.4B6.79%3.97B7.07%1.74B3.30%4.49B2.63%5.13B6.89%3.72B10.19%1.62B14.28%4.35B
Minority profit 17.98%32.86M-11.91%129.32M-8.85%127.88M-12.37%69.64M6.16%27.85M82.70%146.79M53.83%140.3M42.87%79.48M18.82%26.24M-14.61%80.35M
Profit attributable to shareholders 5.23%1.8B5.60%4.59B5.70%5.27B7.21%3.9B7.08%1.71B1.81%4.34B1.67%4.99B6.31%3.64B10.06%1.6B15.02%4.27B
Basic earnings per share 5.18%1.3195.39%3.3635.45%3.8677.11%2.8626.72%1.2541.66%3.1911.52%3.6676.20%2.6729.71%1.17514.73%3.139
Diluted earnings per share 5.18%1.3195.52%3.3635.63%3.8667.11%2.8627.00%1.2541.76%3.1871.58%3.666.24%2.6729.94%1.17214.81%3.132
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------PwC Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -